AOD-9604 is a research peptide designed to do one specific thing: target fat. It's a small, modified fragment of human growth hormone (HGH) — engineered to keep the fat-burning signal while leaving out the effects on blood sugar and tissue growth that come with full growth hormone. For people focused on stubborn fat and metabolic support, that targeted action is the appeal. Here's how it works, what the research shows, and how it's used safely under supervision.
Important: AOD-9604 is a research compound and is not FDA-approved. Human data is limited, and it should only be used under medical supervision.
AOD-9604 (the name stands for Anti-Obesity Drug 9604) is a peptide based on the tail end of the growth-hormone molecule — specifically the portion responsible for fat metabolism. By isolating that fragment, researchers aimed to capture HGH's fat-burning benefit without raising IGF-1 or affecting blood sugar the way full growth hormone can. It's studied as a targeted metabolic and fat-loss compound rather than a general anabolic one.
AOD-9604 is studied for stimulating lipolysis — the breakdown of stored fat — and for inhibiting lipogenesis, the formation of new fat, mimicking the way natural growth hormone signals fat cells to release energy. Because it acts on this specific pathway rather than the broader growth-hormone system, it's researched for supporting fat loss without the appetite, blood-sugar, or tissue-growth effects associated with other approaches. It is not a stand-alone weight-loss drug — it's a tool within a complete program.
Ready to feel like the best version of yourself?
Schedule Your ConsultationIn research and emerging use, AOD-9604 is associated with:
These are research-stage findings, not guarantees, and results vary. AOD-9604 works best alongside nutrition, training, and the rest of a supervised plan — not as a shortcut.
Because AOD-9604 targets fat metabolism directly, some people are interested in it as part of a broader medical weight-loss plan — for example alongside appetite-focused options or other peptide protocols. Whether it fits, and how, is a clinical decision based on your goals and labs.
AOD-9604 is typically given by subcutaneous injection. In available research it's been generally well-tolerated, but human data is limited and it's not FDA-approved as a weight-loss drug — which is why it should be used under medical supervision, not self-sourced online. The form and protocol are individualized; we don't publish dosing.
AOD-9604 tends to interest adults focused on stubborn fat and metabolic support who want a supervised approach. Whether it's appropriate for you depends on your labs, history, and goals, reviewed in a consultation — and if it's not the right fit, we'll discuss alternatives honestly.
We don't sell research chemicals off a shelf. Where appropriate, it's provided only within a physician-supervised plan with proper evaluation, medical-grade sourcing, and monitoring — by providers who specialize in peptides. In person at our Scottsdale clinic or by concierge virtual visit across Arizona.
AOD-9604 is studied for targeted fat loss and metabolic support — a fragment of growth hormone focused on fat metabolism without the broader effects of HGH. It's a research compound and is not FDA-approved as a weight-loss drug.
It's studied for stimulating fat breakdown (lipolysis) and reducing new fat formation, mimicking how growth hormone signals fat cells — but without raising blood sugar or IGF-1 the way full HGH can.
In available research it's been generally well-tolerated, but human data is limited and it's not FDA-approved — which is why supervision and medical-grade sourcing matter.
Book a consultation — in person at our Scottsdale clinic or by concierge virtual visit across Arizona. We'll review your goals and history and tell you honestly whether AOD-9604 is an appropriate option for you.
Customized hormone, peptide, weight-loss, and aesthetic plans built around your body and lifestyle. Confidential consultations available in-office and via telemedicine.
Book Your Consultation